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Purpose: Light-induced damage can be a problem after surgery or sun exposure. Short-duration, intense light causes
preferential photoreceptor death in the superior central retina of albino mice and rats and serves as a model of oxidation-
induced neurodegeneration. Previous work on retinal ischemia-induced neuronal death suggests the involvement of zinc
(Zn2+) toxicity in the death and collapse of many retinal cell layers and demonstrates the protective efficacy of pyruvate.
Retinal pigment epithelial (RPE) cells were shown to be sensitive to oxidative stress, and zinc, causing loss of nicotinamide
adenine dinucleotide (NAD+) and adenine triphosphate (ATP), which was prevented by pyruvate and nicotinamide. We
previously showed similar results in cortical neurons exposed to oxidative stress or Zn2+. In vivo, Zn2+ is normally present
in the inner and outer segments (associated with rhodopsin), Bruch’s membrane and sclera (elastin), RPE, and the outer
plexiform layer of the eye (synaptic). In this study, we examine the role of Zn2+ in oxidative stress and light-induced
damage in vitro and in vivo.
Methods: We modeled retinal toxicity in cell-culture lines derived from retinal tissue: Müller and human retinal pigment
epithelial (ARPE-19) cells and a cone photoreceptor-derived line (661W). These cultures were exposed to Zn2+ and OS,
and the therapeutic efficacy of pyruvate, nicotinamide, and NAD+ was determined. Sprague Dawley albino rats were
exposed to 18 kLux of white fluorescent light for 1–4 h in the presence and absence of pyruvate, nicotinamide, lactate,
and cyclic light. The intracellular free zinc concentration ([Zn2+]i) and cell damage were assessed 0.5 and 7 days later,
respectively.
Results: We show that Zn2+ and oxidative stress results in increased [Zn2+]i and that Zn2+ therapeutic compounds (pyruvate,
nicotinamide, and NAD+) and inhibitors of previously implicated pathways (sirtuin) are efficacious in vitro. Exposure to
18 kLux of cool white fluorescent light for 1 h induced a large increase in Zn2+ staining 4–14 h later, particularly in the
superior outer nuclear layer and RPE of dark-maintained Sprague Dawley albino rats; 4 h of light was required to induce
similar damage in cyclic light-maintained rats. Photoreceptors and RPE cells died in untreated animals at 3–7 days.
However, nicotinamide and pyruvate (intraperitoneal), but not lactate, attenuated this death in treated animals, as measured
using optical coherence tomography and confirmed by counting photoreceptor nuclei.
Conclusions: Zn2+ plays a role in this injury, as suggested by the increased Zn2+ staining and the efficacy of Zn2+
therapeutics. These results suggest that cyclic light maintenance, Zn2+ chelation, pyruvate, and nicotinamide promote RPE
and photoreceptor survival after injury and could be effective for various forms of retinal neurodegeneration. These results
could have immediate clinical applications in surgery- or sun exposure- induced light damage to the retina.
There are many reasons to study light-induced damage to
the retina: Light damage (LD) can occur under bright surgical
lights if the eye patches normally used to block light are
improperly placed or forgotten. Light damage also occurs
during  acute  intense  sun  exposure  (such  as  prolonged
exposure  over  water  or  snow  or  improper  solar  eclipse
viewing); chronic sun exposure has also been implicated in
cataracts [1-5]. Furthermore, light-induced retinal damage is
a physiologically relevant model for oxidation (OS)-induced
retinal neurodegeneration [6,7]. Light or oxidation accelerates
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disease progression in many models of retinal diseases, such
as  retinitis  pigmentosa  (RP)  mutant  mice  [8-11],  Smith-
Lemli- Opitz rats [12,13], and in retinal degenerations [14,
15],  including  Royal  College  of  Surgeons  rats  [16],  age-
related macular degeneration (AMD) [17], glaucoma [18],
Tubby mice [19], and diabetic retinopathy [20]. This was
reviewed  in  [21].  Thus,  therapeutics  that  are  efficacious
against oxidation- or light-induced damage should also be
effective against these retinal degenerative diseases.
Retinal ischemia-mediated neuronal death is associated
with an increase in zinc (Zn2+), and pyruvate or nicotinamide
attenuates this death in vitro and in vivo by restoring NAD+
levels [22,23]. Intra-ocular injection of 1–10 nanomoles of the
Zn2+ chelators, EDTA-calcium salt (CaEDTA), or N,N,N'N'-
tetrakis(-)[2-pyridylmethyl]-ethylenediamine  (TPEN)
attenuates neuronal death induced by retinal ischemia [24].
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2639Higher levels of these chelators can induce retinal detachment
[22]. Either extracellular Zn2+ uptake through voltage gated
Ca2+ channels or OS-induced intracellular Zn2+ release from
Zn2+ binding proteins or organelles are neurotoxic. Previous
chelator, metabolic, and zinc transporter 3 (ZnT3 and slc30a3)
knockout studies have demonstrated that synaptically released
zinc  contributes  to  neuronal  death  after  global  ischemia,
hypoglycemia, or seizures [25-27]. Intracellular Zn2+ release
contributes to focal ischemia, OS-, or trophic deprivation-
induced neuronal death [28,29]. Pyruvate or nicotinamide can
attenuate these zinc neurotoxicities in vitro and in vivo in part
through restoration of NAD+ levels lost due to Zn2+ exposure;
this NAD+ restoration restores glycolytic flux [28,30-33]. We
are interested in the role of excess zinc in retinal degeneration
as  a  result  of  pathologic  light  exposure  and  oxidative
conditions. In ambient light, Zn2+ is present physiologically in
layers of the eye, most notably in the rod inner and outer
segments (RIS, ROS) of the outer nuclear layer (ONL), the
outer plexiform layer (OPL), and retinal pigment epithelial
(RPE) cells. However, in the dark, the RIS and ROS segmental
Zn2+ disappears and Zn2+ appears in photoreceptor perikarya
of  the  ONL.  Zn2+  serves  important  functions,  such  as
modulating  neurotransmission  [34,35],  regulating
intracellular metabolism, and dark-light adaptation in retina
[reviewed in 36]. The “stainable, releasable” Zn2+ has been
demonstrated through auto-metallographic staining [36-38]
and fluorescent dye staining [22,36,39] and Zn2+ has been
shown  to  be  synaptically  released  in  the  OPL  through
photoreceptor activity [39,40].
The  pathway  we  studied  was  that  elevation  of
intracellular Zn2+ can cause a reduction in NAD+ and ATP
levels,  causing  dysfunction  of  glycolysis  and  cellular
metabolism [30,32]. In the experiments presented here, we
used the light-induced retinal damage model in albino rats.
Oxidative stress has been shown to be involved in this model
in the initiation of damage after intense light exposure. In
addition, endoplasmic reticulum (ER) stress has also been
shown to occur after LD and in rhodopsin RP mutants, and
degeneration could be attenuated by overexpression of ER
chaperone proteins, perhaps reflecting excessive shedding or
misfolding of ROS proteins [41,42]. Previous studies have
shown that intense light-induced photoreceptor and RPE cell
death is greater in the superior central retina compared to the
inferior retina, as measured by ONL thickness and counting
[43,44]. This damage involves specific prolonged apoptotic
rod cell death and rapid necrosis cone cell death; the roles for
DNA damage and repair have been established [reviewed in
21,43].  In  our  study,  we  investigated  whether  light-  and
radical-induced damage of retinal cells or cell lines causes
toxic zinc accumulation, and whether pharmacologic Zn2+
therapeutics, which restore NAD+ levels, are effective in vitro
and in vivo.
METHODS
Cell culture: A Müller cell line and the ARPE-19 cell line
were  maintained  in  Dulbecco’s  Modified  Eagle  Medium
(DMEM)  media  containing  10%  fetal  bovine  serum  and
penicillin/streptomycin. The 661W cone photoreceptor cell
line  was  maintained  in  the  same  medium  with
supplementation of 2-mercaptoethanol, hydrocortisone 21-
hemisuccinate, progesterone, and putrescine [45-47]. Some
661W cultures were preloaded and grown with an additional
10 μM Zn2+ for 2 days before toxicities (~13 μM Zn2+ total in
plating  medium).  This  Zn2+  concentration  does  not  cause
toxicity or affect growth, but does increase basal [Zn2+]i [28].
Cells were grown in 5% CO2 in 95% humidity at 37 °C for 2
days after splitting to achieve 50%–70% confluency at the
time  of  the  experiment.  Cells  were  exposed  to  zinc  (10–
200 μM), ethacrynic acid (ETH; 15–100 μM), and H2O2 (100–
400 μM) for 24 h in minimal essential medium.
Cell viability assay: The cells (50%–70% confluent) were
exposed to zinc, ETH, and H2O2 in the presence of 1–10 mM
pyruvate, NAD+, or nicotinamide, and 0.03–0.5 μM TPEN or
3–20  μM  of  the  sirtuin  pathway  inhibitor,  sirtinol.  Cell
viability was determined by measuring lactate dehydrogenase
released  into  the  medium  after  24  h.  For  cells  that  were
exposed to NAD+, cell viability was determined by MTT assay
or PI staining assay [48]. Twenty-four h after exposure, cells
were stained with 0.1% MTT for 30 min at 37 °C, lysed, and
absorbance measured at 595 nm, or PI was added (5 μg/ml)
for 30 min at 37 °C and fluorescence measured (ex 530/em
645).
Live-cell  imaging:  FluoZin3  AM  (5  μM;  Invitrogen/Life
Technologies, Carlsbad, CA) was pre- or post-loaded in the
cell lines for 30 min at 37 °C, washed, and exposed to toxic
Zn2+, ETH, or H2O2 for 1–11 h before photomicrographs of
identical duration were taken.
Rat light damage model: Sprague Dawley albino rats (Charles
River,  Wilmington,  MA)  weighing  150–175  g  were
acclimated for 5 days to a cyclic, dim overhead fluorescent
light (30 Lux), followed by a 60 h dark adaption. At this point,
one group of animals (dark) was maintained totally in the dark
for the duration of the experiment, using red light illumination
to  dilate  their  eyes  (1%  tropicamide  ophthalmic  solution
USP), and was returned to their cages after 1–2 h of light
exposure. The second group of rats (light) had their eyes
dilated in room light after the 60 h dark adaptation, were
exposed to 4 h of light damage, and were returned to cyclic
light after 24 h recovery in the dark. The animal chamber was
rotated during the light exposure to ensure that the animals
were awake with their eyes open. Rats were exposed to bright
cool white fluorescent light from 8x 20W-circular fluorescent
bulbs (18,000 Lux) [43] in the presence or absence of 500 mg/
kg intraperitoneal (i.p.) pyruvate or nicotinamide (3×/week).
This was followed by recovery in the dark for 24 h (light) or
7 days for the dark maintained animals (dark). After 24 h
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2640recovery in the dark, the (light) group was returned to the
cyclic, dim overhead fluorescent light environment for 6 days.
All  studies  were  conducted  within  the  guidelines  (stated
above) established by the Institutional Animal Care and Use
Committee  (Louisiana  State  University  Health  Sciences
Center, New Orleans), and were in accordance with the PHS
Guide for the Care and Use of Laboratory Animals, USDA
Regulations, and the AVMA Panel on Euthanasia guidelines.
Optical  coherence  tomography:  Optical  coherence
tomography  (OCT)  is  an  optical  signal  acquisition  and
processing  method  providing  extremely  high-quality,
micrometer-resolution,  three-dimensional  images  from
within  optical  scattering  media  (Spectralis,  Heidelberg
Engineering, Heidelberg, Germany). On the 7th day after light
damage, rats were anesthetized with ketamine and xylazine
and OCT was performed to measure the thickness of the ONL.
A real-time eye tracker was used to couple cSLO and SD-OCT
scanners to position and stabilize the OCT scan on the retina.
Scaling X was 3.24–3.31 µm/pixel; scaling Z was 3.87 µm/
pixel. The built-in scale bar was used when performing OCT
analysis. The thickness of the ONL was measured from the
bottom edge of the outer plexiform layer to the top edge of the
RIS.
Retinal histology: After OCT, rats were sacrificed by CO2
asphyxiation.  Eyes  were  fixed  in  2%  formaldehyde/2%
glutaraldehyde and cut in half along a superior-to-inferior
meridian through the center of the optic nerve. After a 1 h
fixation  period  in  1%  osmium  tetroxide  and  sequential
dehydration in ethanol, eyes were embedded in plastic resin
(Electron  Microscopy  Systems,  Hatfield,  PA).  Retinal
sections of 1.5 microns were cut, mounted on glass slides, and
stained with 0.1% toluidine blue. The number of ONL nuclei
was counted on sections from 6 different retinas at increasing
distances  from  the  optic  nerve  on  the  superior-to-inferior
meridian. Pictures were taken in the mid-superior and mid-
inferior hemispheres.
Retinal Zn2+ staining: Eyes of Sprague Dawley rats were
collected 4 and 14 h after 1 or 4 h of light exposure with or
without dark maintenance, respectively. For example, 4 h LD
(light) + 4 h refers to an animal that had its eyes dilated in
normal light (not red light) before undergoing 4 h of light
damage; the animal was then sacrificed 4 h after light damage.
Fresh frozen cryostat sections (10 microns) were prepared,
dried,  and  stained  with  5  μM  ZinPyr-1  (ZP1,  TefLabs,
Galveston,  TX)  for  2  min,  washed  with  PBS,  and  then
photomicrographs were taken immediately using the exposure
times indicated (ex: 480nm; em: 530nm). Note that to prevent
complete  saturation  of  the  images,  exposure  times  were
varied. There was no autofluorescence at this wavelength
either  basally  or  after  light  damage,  and  staining  was
prevented by pretreatment with the zinc specific chelator,
TPEN (data not shown).
Reagents:  All  materials  were  purchased  from  Sigma
Chemical Co. (St. Louis, MO) unless otherwise stated.
RESULTS
Zinc and oxidative stress induce [Zn2+]i increases in cone
photoreceptors, ARPE-19 cells, or Müller cells: We examined
whether zinc (30–200 μM), ETH (10–100 μM), and H2O2
(100–400 μM) induced a [Zn2+]i increase in Müller, ARPE-19,
or 661W cone photoreceptors. Cultures were pre- or post-
loaded with 5 μM FluoZin3 AM for 30 min and then washed
out and exposed to oxidative stress as indicated. We found
that after 1–11 h, [Zn2+]i was increased after Zn2+ or oxidative
exposure in each of these cell lines (Figure 1). The increase
in Fluo-Zin3 staining was specific for Zn2+ as demonstrated
using the intracellular zinc chelator, TPEN. The extracellular
zinc chelator, CaEDTA, was ineffective except for exogenous
Zn2+ exposure, perhaps due to the intracellular release of zinc
and the short 1–5 h exposure to CaEDTA (data not shown).
Pyruvate, nicotinamide, or NAD+ are not expected to affect
[Zn2+]i  because  they  had  no  effect  on  [Zn2+]i  in  cortical
neurons, but did restore NAD+, glycolytic flux, and prevented
Zn2+ neurotoxicity.
Zinc-  and  oxidative-stress-induced  death  of  cone
photoreceptors  or  Müller  cells  was  attenuated  by  Zn2+
therapeutics:  TPEN,  pyruvate,  nicotinamide,  NAD+,  or
sirtinol (Zn2+ therapeutics) can protect cortical neurons from
zinc and oxidative toxicities in vitro or in vivo [28,30,32].
Chronic  addition  of  these  Zn2+  therapeutic  compounds
attenuated zinc and oxidative-stress-induced death of Müller
or ARPE-19 cells and 661W cone photoreceptors as measured
using lactate dehydrogenase release to the media, 5 μg/ml PI
staining,  or  0.1%  MTT  staining  [49].  Zn2+  preloading
potentiated oxidative-stress-induced toxicity in 661W cells.
The respective LD50 for zinc, ethacrynic acid, and H2O2 was
60 μM, 60 μM, and 200 μM for 661 W cells; 100 μM, 30 μM,
and  600  μM  for  Müller  cells;  and  90  μM,  20  μM,  and
300 μM for ARPE-19 cells. Chronic additions of 3–10 mM
pyruvate or nicotinamide or 3–6 mM NAD+ were consistently
efficacious  across  toxicities.  The  resultant  cell  death  was
variably attenuated by 3–20 μM sirtinol, whereas 10 mM
lactate was consistently ineffective or detrimental. Zn2+ pre-
loading potentiated, and 0.03–0.5 μM TPEN attenuated these
injuries (Figure 2). The effective concentration of TPEN was
lower in Müller cells due to their tendency to detach from the
plate at higher concentrations of TPEN.
Light damage increases Zn2+ staining in photoreceptors: We
performed  time  courses  of  zinc  accumulation  after  light-
induced damage using a zinc fluorescent dye (5 μM ZP1) on
fresh  frozen  dried  rat  retinas.  Figure  3  shows  that  zinc
accumulated preferentially in the mid-superior RPE and the
superior  photoreceptors  of  the  ONL  at  4–14  h  after  light
damage, which is before the onset of cell death induced by
light (48–96 h). The two previously mentioned layers are the
most sensitive to LD. Zinc staining started at 2 h, and was
maintained at 24 h after LD (data not shown). More zinc-
stained photoreceptors were present in the mid-superior than
Molecular Vision 2010; 16:2639-2652 <http://www.molvis.org/molvis/v16/a283> © 2010 Molecular Vision
2641in the mid-inferior retina, correlating with the sensitivity of
these regions to LD. The stain was specific for Zn2+ because
at 480 nm excitation, there was no autofluorescence and no
staining after TPEN pretreatment (data not shown). We also
show that Zn2+ staining and accumulation in ROS, RIS, and
photoreceptors after only 1 h of LD was much more prevalent
when animals were kept dark-adapted and if the eyes were
collected and frozen in the dark (note exposure times). This
may be due to the depolarization of photoreceptors in the dark,
which allows Zn2+ influx through voltage-gated Ca2+ channels
[50]. Because Zn2+ staining must be performed on fresh frozen
dried  tissue  sections,  the  morphologic  preservation  of  the
tissue was not perfect. However, the inner and outer segments,
ONL, RPE, and plexiform layers were still easily discernible,
and the increase in the number of superior photoreceptors and
RPE cells that stained for Zn2+ at 4–14 h was greater than the
increase in inferior photoreceptors and RPE cells. The entire
superior ONL, ROS, RIS, and RPE layers were destroyed after
3–7  days  (see  below),  and  these  were  the  layers  that
preferentially stain with Zn2+ 4–14 h after LD.
Light  damage  induced  death  of  photoreceptors  in  vivo:
Treatment  with  pyruvate  or  nicotinamide  (i.p.)  attenuated
damage to the superior retina, as shown 7 days post-LD by
optical coherence tomography (Figure 4), and by ONL cell
counting of plastic sections (Figure 5 and Figure 6). Rats
exposed to 4 h of 18 kLux white fluorescent light followed by
cyclic light displayed complete loss of the superior central
ONL,  including  the  RIS,  ROS,  and  the  RPE,  and  ~10%
photoreceptor death in the inferior central ONL, as previously
reported [43,44,51]. Pre-treatment with i.p. pyruvate, but not
lactate, afforded substantial protection of the photoreceptors
and RPE cells against light damage, and partial protection of
RIS and ROS (Figure 4 and Figure 5); nicotinamide provided
complete protection to photoreceptors, RIS, ROS, and RPE
cells (Figure 4, Figure 5, and Figure 6). Quantitations of ONL
thickness, measured as the distance between the RIS and the
OPL (arrow or bar), were made by OCT, and are plotted in
Figure 4B. Figure 5B presents the number of photoreceptor
nuclei at increasing distances superior or inferior to the optic
nerve.
Data analysis and statistics: The changes in retinal cell death
were  determined  in  cultures  under  the  conditions  stated.
Means±SEM are plotted and the number is given for each
experiment in the figure legends. Results were compared to
sham wash or saline injection controls and toxin or injury
exposure  alone.  A  one-way  ANOVA  was  used  to  assess
variance in each set of experiments, followed by a Bonferroni
test. Significance was achieved by a p value of less than 0.05.
DISCUSSION
In these experiments, we show that: 1) Intense light can induce
zinc accumulation in the retina, particularly in the RPE, ROS,
RIS, sclera, OPL, and photoreceptors. The early, preferential
accumulation  of  zinc  in  the  superior  photoreceptors  after
light-induced damage (before ONL cell death) suggests that
zinc  may  play  a  role  in  the  death  of  these  cells  in  vivo.
Potentiation of Zn2+ accumulation and injury by maintenance
of dark adaptation/depolarization supports this notion. 2) The
superior  retina  is  more  sensitive  to  light-induced  damage
compared to the inferior retina, and pyruvate or nicotinamide
(i.p.) can attenuate photoreceptor cell death as shown by OCT
and  plastic  sections.  3)  In  vitro,  pyruvate,  nicotinamide,
Figure 1. Zinc (Zn2+), or oxidative stress induces an increase in intracellular free zinc concentration ([Zn2+]i). Cultures of Müller, ARPE-19,
and 661W cells were pre- or post-loaded with 5 μM FluoZin3 AM and exposed to 60–300 μM Zn2+, 30–60 μM ethacrynic acid, and 200–400
μM H2O2, as indicated. Representative photomicrographs (n=6) of identical exposure were taken at the times shown.
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2642sirtinol, NAD+, and, perhaps, TPEN can attenuate Müller,
ARPE-19, and 661W cone cell death induced by zinc and
oxidative stress.
We  and  others  have  previously  shown  that  Zn2+
accumulates  in  cortical,  thalamic,  and  striatal  neurons
exposed to extracellular Zn2+ or oxidative stress, and that
Figure 2. Zn2+ or oxidative-stress-induced death was attenuated by Zn2+ therapeutics. A: Pyruvate, nicotinamide, NAD+, TPEN, and sirtinol
variably attenuated ethacrynic acid, H2O2, or zinc toxicity in the 661 W cone photoreceptor cell line. B: The effect of these exposures on
Müller glial cells is presented. C: The effect of these exposures in ARPE-19 cells is presented (n=10–15). * indicates difference from toxic
exposure alone at p<0.05 by one-way ANOVA and a Bonferroni test.
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2643Zn2+ chelators or compounds that restore NAD+ levels and
glycolysis (Zn2+ therapeutics) attenuate injury [28,30,32,52,
53]. We now show that these Zn2+ therapeutics were also
effective in retinal cells in vitro and in vivo. These compounds
have been shown to prevent Zn2+ neurotoxicity by restoring
NAD+ levels and glycolytic flux; this may be their mechanism
of  action  against  light-induced  damage  as  well.  The
mechanisms of Zn2+ toxicity has been shown to be multi-
factorial, and they include affects on increasing autophagy
[54], damaging mitochondria inducing metabolic dysfunction
[55,56],  inhibiting  protein  phosphatases  causing  kinase
cascade  activation  [53,57],  and  inducing  OS  through
activation of nicotinamide adenine dinucleotide phosphate
oxidase  [58-60].  Importantly,  chelator  compounds,  Zn2+
reducing manipulations, and manipulations demonstrated to
restore  NAD+  (pyruvate,  nicotinamide,  poly-ADP  ribose
polymerase (PARP) inhibition, slow Wallerian degeneration
(Wlds))  have  displayed  in  vivo  efficacy  against  Zn2+
neurotoxicity,  but  the  alternate  pathways  described  above
have  limited  evidence  for  in  vivo  efficacy  [22,28,31-33,
61-64].
High  levels  of  Zn2+  also  have  been  found  in  the
aggregated proteins that comprise drusen in AMD [65]. This
is similar to the presence of high levels of Zn2+ in amyloid
plaques of Alzheimer disease [66,67]. Zn2+ chelation has been
proposed  as  a  therapy  for  Alzheimer  disease  [68],  and  a
chelator from DPharm (DP-b99) is being tested in phases II
and III Alzheimer clinical trials. This chelator also has proven
effective against stroke [69]. This is in contrast to the use of
Zn2+ as a supplement in the AREDS trial against AMD. Zn2+
was used in the AREDS trial because it has been reported to
be beneficial in the immune system, where it may cause an
antioxidant response [reviewed in 70]. However, due to Zn2+
accumulation  after  ischemia,  injury,  and  in  drusen,  many
researchers  have  recently  questioned  the  use  of  Zn2+
supplementation in AMD treatment.
However, it should also be noted that too little Zn2+ in the
retina has been shown to be detrimental. Zn2+ deficiency in
Figure 3. Light-induced damage caused Zn2+ accumulation preferentially in superior photoreceptors, retinal pigment epithelial (RPE), rod
outer segments (ROS), and outer plexiform layer (OPL). Light-induced damage (LD) was performed and fresh frozen rat retinas were analyzed
at 4 or 14 h after 1 h of light damage in dark maintained conditions (dark) or after 4 h of light damage in non-dark maintained conditions
(light). Zn2+ accumulation (white regions) was assessed by ZP1 staining of fresh frozen rat eye cryostat sections cut at 10 microns, which were
dried and stained in 5 μM ZP1 for 2 min. Representative photomicrographs (n=4) were taken of the mid inferior and mid superior regions of
the retina at 5 s exposure for: control, 4 h LD (light) + 4 h, and 1 h LD (dark) + 4 h; at 1 s exposure for: 1 h LD (dark) + 14 h; and at 2 s
exposure for: 4 h LD (light) + 14 h, and 1 h LD (light) + 14 h. Layers are as marked. Notice the large increase in the number and intensity of
Zn2+ stained cells in superior ONL (brackets), ROS, and RPE. Light=non-dark maintained, Dark=dark maintained.
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2644Figure 4. Optical coherence tomography (OCT) scans demonstrate protection of ONL by pyruvate and nicotinamide against LD. A:
Representative ONL images were taken from OCT in control, 7 days after 4 h light damage in non-dark conditions (4 h LD (light)), 4 h LD
(light) + P, 4 h LD (light) + N, and 4 h LD (light) + L, where P, N, and L refer to 500 mg/kg i.p. injection before LD and 3x/week of pyruvate,
nicotinamide, or lactate, respectively. Bar represents 50 microns. B: The mean thickness in central superior and central inferior hemispheres
(arrow or bar in A) of the retina in microns after these exposures is presented ± SEM (n=6). * indicates difference from control, # indicates
difference from light damage, and $ indicates difference between dark maintained and non-dark maintained retinas at p<0.05 by one-way
ANOVA and a Bonferroni test.
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2645Figure 5. Plastic sections confirm protection of ONL by pyruvate and nicotinamide against LD. A: Plastic sections were cut from eyes along
a superior to inferior meridian encompassing the optic nerve and stained with 0.1% Toluidine Blue. Representative photo-micrographs were
taken of the mid superior and mid inferior regions from each of the groups as designated in Figure 4. Bar represents 50 microns. B: The mean
number of nuclei at increasing distance from the optic nerve on the superior and inferior sides was averaged and plotted as a function of
distance from the optic nerve for each of the experimental conditions above (n=6). # signifies difference from LD at p<0.05 by one-way
ANOVA and a Bonferroni test.
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2646Figure 6. Plastic sections confirm potentiation of ONL loss by dark maintenance and protection by nicotinamide against LD. A: Plastic sections
were cut from eyes along a superior to inferior meridian encompassing the optic nerve, and were stained with 0.1% Toluidine Blue.
Representative photo-micrographs were taken of the mid superior and mid inferior regions from Control group; 1 h light-induced damage
dark-maintained (1 h LD (dark)) group; LD + i.p. injection of nicotinamide (1h LD (dark) + N); and 2 h of LD dark maintained (2 h LD (dark))
versus non dark maintained (2 h LD (light)) as marked. B: The mean number of nuclei at increasing distance from the optic nerve on the
superior and inferior sides was averaged and plotted as a function of distance from the optic nerve for each of the experimental conditions
above (n=6). # signifies difference from LD at p<0.05 by one-way ANOVA and a Bonferroni test.
Molecular Vision 2010; 16:2639-2652 <http://www.molvis.org/molvis/v16/a283> © 2010 Molecular Vision
2647patients with chronic alcoholic cirrhosis or pancreatitis may
reversibly impair dark adaptation, electroretinography, and
induce structural defects in the periphery of the retina [71,
72]. Also, a chronic Zn2+ deficient diet [73], or Zn2+ chelation
[74], resulted in osmiophilic lipid inclusion bodies in the RPE,
and ROS disruption.
In  these  experiments  on  the  role  of  Zn2+  in  retinal
neurodegeneration, we used a light-induced retinal damage
model for albino rats. Light damage has been shown to cause
both direct DNA damage and oxidative DNA damage, both
of which can activate PARP, resulting in NAD+ loss [75].
Furthermore,  light  damage  in  the  eye  has  been  shown  to
activate PARP, and antioxidants attenuate PARP activation
and LD of photoreceptors [76]. We performed time courses
of zinc accumulation after light-induced damage using a zinc
fluorescent dye on fresh frozen rat retina to demonstrate the
accumulation  of  zinc  in  the  RPE  and  ONL  before  light-
induced cell death. This Zn2+ accumulation was especially
prevalent 4–14 h post-exposure in the superior versus the
inferior central retina, which is where photoreceptors are most
vulnerable to light damage. Zn2+ accumulation peaked more
than 20 h before photoreceptor death occurred, and it was most
prevalent in the ROS and in dark-maintained animals. RPE
cells also accumulated significant Zn2+, which may be the
result of their involvement in the clearance of shed outer
segments  that  contain  significant  Zn2+  in  association  with
rhodopsin. Zn2+ has been shown to be a structural component
of  rhodopsin,  which  is  critical  for  its  stability,  cis-retinal
binding, and function in the dark state [77,78]. In addition,
substantial Zn2+ staining also occurred in the sclera, especially
after light damage. This was likely due to the tight binding of
zinc by the membrane protein elastin.
Photons are absorbed in the outer segments by rhodopsin,
changing  its  structure  and  resulting  in  activation  of  the
phototransduction  cascade  and  photoreceptor
hyperpolarization.  Therefore,  light  stimulation  induces
hyperpolarization and dark adaptation induces photoreceptor
depolarization, which potentiates Zn2+ influx through voltage-
gated calcium channels [50,79,80]. A similar situation seems
to occur in the retina, where LD and zinc accumulation was
greatest  if  the  retina  was  completely  dark  adapted  (and
therefore depolarized) before and after LD [81,82]. These data
implicate Zn2+ influx into photoreceptors in LD. Also, the
stainable Zn2+ pool in the retina is dramatically affected by
dark  adaptation.  As  stated  previously,  Zn2+  is  located  in
specific retinal layers in adults exposed to ambient light, but
Zn2+  is  especially  found  in  the  inner  segments  of
photoreceptors. Dark adaptation results in the stainable zinc
pool disappearing from the RIS and appearing in the cell
bodies of most photoreceptors [36]. The light-dark staining
pattern  in  RIS  can  be  explained  by  an  interaction  with
rhodopsin  (see  below),  but  the  pattern  in  photoreceptor
perikarya suggests an unknown Zn2+ binding/translocation
protein  interaction.  It  is  also  interesting  to  note  that  Zn2+
deficiency results in a loss of night vision [71,83], which
suggests that this dark-induced change in Zn2+ staining may
be functionally relevant.
Grimm and colleagues demonstrated effective LD using
only 2 h of exposure to 15 kLux white light when pigmented
mice were completely dark-maintained before and after LD
[84]. Mice maintained in this manner are more sensitive to
LD, perhaps due to depolarization of photoreceptors in the
dark state and the movement or release of Zn2+ from the inner
segments  to  the  photoreceptor  cell  bodies,  which  may
potentiate injury (Figure 3B) [36]. Some researchers have not
demonstrated this degeneration in pigmented mice with 2 h
LD, but the dark-adapted state may not have been maintained.
In Figure 4B and Figure 6, we show that 2 h of LD with dark
maintenance  causes  substantially  more  injury  than  if  the
albino rats are not dark-maintained. Only 1 h of LD causes
almost complete loss of superior photoreceptors in albino
Sprague  Dawley  rats  (as  determined  by  OCT  and  plastic
sectioning), while 4 h of light damage was required if animals
were returned to light.
Where does the Zn2+ come from to induce the massive
increase in Zn2+ staining observed in the ROS and ONL after
LD? In the inner and outer segments, rhodopsin has been
shown to bind to and require one ion of Zn2+, which stabilizes
the  structure  and  organization  of  rhodopsin  into  disc
membranes [85,86]. The amino acids involved in this high-
affinity, required, tetrahedral Zn2+ binding site are Glu122 (at
the end of transmembrane region 3), and His211 (at the end of
transmembrane region 5). This Zn2+ coordination site lies
within the 11-cis-retinal binding pocket and is critical for the
stability  of  this  chromophore-receptor  interaction  and  for
proper rhodopsin folding in the inactive (dark) state. Binding
of  additional  Zn2+  ions  (>  1)  to  rhodopsin  through  lower
affinity sites (His100 and His195) has been suggested to induce
a destabilization that might help RPE cells (with a high basal
Zn2+ content) degrade rhodopsin from shed outer segments.
Many of the RP rhodopsin mutations cluster around the amino
acids involved in Zn2+ binding (His100 and His195), and the
His211-Pro or -Arg and the Pro23-His RP mutations have been
suggested  to  affect  Zn2+  binding  and  reduce  rhodopsin
stability  [77,78].  Light  activation  also  induces  structural
changes  increasing  the  distance  between  TM  3  and  5  of
rhodopsin, which increases the tetrahedral binding distance
for  Zn2+;  this  is  inconsistent  with  continued  Zn2+  binding
[77,87]. We therefore predict Zn2+ release from rhodopsin by
light exposure, which is supported by our data (Figure 3).
Rhodopsin (Rho) knockout (KO) mice lack opsin synthesis,
do not develop an ROS structure, and do not activate the
required apoptotic AP-1/c-fos transcription factor in response
to  LD.  Photoreceptors  from  Rho  KO  mice  spontaneously
degenerate starting at 3 months of age, but at 1–2 months of
age Rho KO photoreceptors are resistant to LD [84,88,89].
RPE65 KO prevents re-isomerization of all-trans retinol in the
visual cycle, and thereby prevents rhodopsin regeneration and
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2648rod  function.  RPE65  KO  mice  also  do  not  show  any
photoreceptor death after LD [84,90]. C-fos/AP-1 KO mice
were also insensitive to LD [91] and increased [Zn2+]i activates
kinase  cascades  that  activate  c-fos/AP-1  [53,58,92].  A
diffusible light damage-induced factor has been postulated in
the literature [21,36,84], and it is possible that Zn2+ is this
factor. We postulate that Zn2+ is released from rhodopsin by
light and moves to the RIS and cell body, allowing Zn2+
staining  and  c-fos/AP-1  activation.  The  regenerated
rhodopsin then rebinds this zinc in the ER of the RIS in the
dark and RIS staining goes away, thus accounting for the RIS
light-dark Zn2+ staining pattern.
Immediate post-LD treatment with these compounds is
ongoing and may be effective since it has been shown that
pyruvate  and  nicotinamide  are  effective  for  1–2  h  after
ischemia,  hypoglycemia,  and  trophic  deprivation  [26,28,
30-33]. Studies involving eye drop application of pyruvate or
nicotinamide  are  also  ongoing,  and  this  route  of
administration may be effective because topical application
of pyruvate was shown to penetrate the human cornea [93].
We are also studying the efficacy of reducing retinal Zn2+
through chelators and diet to affect Zn2+ staining and LD, as
well as the potentiation of LD by dark maintenance. Finally,
we plan to examine the zinc staining of the Rho and RPE65
KO animals and the efficacy of pyruvate and nicotinamide
against rhodopsin RP mutant models of retinal degeneration.
These experiments have validated the therapeutic efficacy of
pyruvate and nicotinamide against the light-induced retinal
damage model in rat and have implicated an increase in retinal
Zn2+ accumulation in this injury.
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